2025
Rates of anxiety disorders, mood disorders, and substance use disorders in federally qualified health centers, 2019-2022
Tsai J, Witte L, Schick V. Rates of anxiety disorders, mood disorders, and substance use disorders in federally qualified health centers, 2019-2022. Psychiatry Research 2025, 348: 116457. PMID: 40147089, DOI: 10.1016/j.psychres.2025.116457.Peer-Reviewed Original ResearchSubstance use disordersDrug use disordersMood disordersDiagnosis of mental healthAlcohol-related disordersFederally Qualified Health CentersUse disorderMental healthRates of anxiety disordersCOVID-19 pandemicTrauma-related disordersDiagnosis of anxietyU.S. statesAnxiety disordersHealth centersComprehensive health care servicesHealth care servicesPatient populationQualified Health CentersUniform Data SystemDisordersCOVID-19PatientsMoodNational dataLow Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit their Clinical Utility
Mollon J, Schultz L, Knowles E, Jacquemont S, Glahn D, Almasy L. Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit their Clinical Utility. Biological Psychiatry 2025 PMID: 40113122, DOI: 10.1016/j.biopsych.2025.03.006.Peer-Reviewed Original ResearchAlcohol use disorderPolygenic risk scoresSchizophrenia polygenic risk scoresPercentage of individualsHigh riskDepressive disorderLack of clinical utilityUse disorderValidity of polygenic risk scoresSchizophreniaClinical utilityMDDRisk scoreEffect sizeSNP effect sizesWhite British individualsDisordersHigh-risk individualsUK BiobankType 2 diabetesBritish individualsPRS-CSIndividualsT2DPsychiatryThe therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies
Weleff J, Pulido-Saavedra A, Aghaei A, Ing K, Arakelian M, Fontenele R, Nero N, Barnett B, Anand A, Bassir Nia A, Angarita G. The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies. Psychiatry Research 2025, 348: 116446. PMID: 40147088, DOI: 10.1016/j.psychres.2025.116446.Peer-Reviewed Original ResearchOpioid use disorderStudies of psychedelicsSystematic review of clinical studiesUse disorderReview of clinical studiesTherapeutic effects of psychedelicsEffects of psychedelicsOpioid receptor systemApplications of psychedelicsClinical studiesMu-opioid receptorsNaturalistic studySerotonergic psychedelicsOpioid withdrawalPlacebo-controlled trialPsychedelicsSubstance useUnited States Food and Drug AdministrationStates Food and Drug AdministrationMu-opioidFood and Drug AdministrationSystematic reviewReceptor systemClinical study designDouble-blindCannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
Fink D, Samples H, Malte C, Olfson M, Wall M, Alschuler D, Simpson T, Mannes Z, Saxon A, Hasin D. Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients. International Journal Of Drug Policy 2025, 138: 104765. PMID: 40058102, PMCID: PMC11967342, DOI: 10.1016/j.drugpo.2025.104765.Peer-Reviewed Original ResearchConceptsUrine drug screensCannabis use disorderMedical cannabis lawsVeterans Health AdministrationCannabis useRecreational cannabis lawsRates of cannabis use disordersCannabis lawsEmergency departmentIndicators of cannabis useUrine toxicology testsIncreased cannabis useDifference-in-differences analysisLegalized cannabis useEmergency room patientsSelf-reported dataBinomial regression modelsED visitsED patientsHealth AdministrationCannabis involvementPatient samplesPatientsUse disorderCannabisA multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis
Peng P, Hao Y, Zhang X, Ma Y, Liu X, Shen D, Shen W, Zhao B, Li D, Beck S, Nunez Y, Potenza M, Gelernter J, Liu T, Yang B. A multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis. Annals Of General Psychiatry 2025, 24: 12. PMID: 40033412, PMCID: PMC11877697, DOI: 10.1186/s12991-025-00546-0.Peer-Reviewed Original ResearchSemi-Structured Assessment for Drug Dependence and AlcoholismDSM-5 diagnostic criteriaGambling disorderDSM-5Antisocial personality disorderMethamphetamine use disorderSubstance use disordersDiagnostic criteriaPersonality disorderBridge symptomsDepressive episodeDrug rehabilitation centersCentral symptomsPsychiatric diagnosisGambling durationUse disorderSelf-harmChildhood experiencesMethamphetamineAlcohol useViolent experiencesDisordersManifest symptomsChinese versionMDERetention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opiod use disorder in the United States
Ivasiy R, Madden L, Johnson K, Machavariani E, Ahmad B, Oliveros D, Tan J, Kil N, Altice F. Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opiod use disorder in the United States. International Journal Of Drug Policy 2025, 138: 104748. PMID: 40020306, PMCID: PMC12045481, DOI: 10.1016/j.drugpo.2025.104748.Peer-Reviewed Original ResearchConceptsOpioid use disorderSL-BUPXR-BUPUse disorderRetrospective cohort studyExtended-release buprenorphineReduce treatment discontinuationDays of supplyTreatment discontinuationSublingual buprenorphineReduce overdose riskBuprenorphine treatmentCohort studyHigh dosesPrimary outcomeImpact of dosagePatientsBuprenorphineMonthsMg/dayCommercially-insured individualsProportion of individualsOpioidOverdose riskImprove health outcomesN-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder
Engeli E, Preller K, Rieser N, Klar J, Staempfli P, Hulka L, Kirschner M, Seifritz E, Herdener M. N-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder. Frontiers In Psychiatry 2025, 15: 1489194. PMID: 40083914, PMCID: PMC11903417, DOI: 10.3389/fpsyt.2024.1489194.Peer-Reviewed Original ResearchCocaine use disorderSuperior frontal gyrusCue reactivityCocaine cuesUse disorderFrontal gyrusPrefrontal regionsResponse to cocaine cuesTreating cocaine use disorderDuration of cocaine useModulation of glutamatergic signalingCue reactivity paradigmCue-induced activationDrug cue reactivityIncreased cue reactivityNeural cue reactivityCue-induced cravingMedial prefrontal regionsRisk of substance usePlacebo-controlled cross-over trialAlleviate cravingCocaine cravingCocaine picturesNucleus accumbensRelapse behaviorAuthor Correction: A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine D2/3 receptor densities
Ricard J, Labache L, Segal A, Dhamala E, Cocuzza C, Jones G, Yip S, Chopra S, Holmes A. Author Correction: A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine D2/3 receptor densities. Communications Biology 2025, 8: 293. PMID: 39988590, PMCID: PMC11847929, DOI: 10.1038/s42003-025-07723-7.Peer-Reviewed Original ResearchEmbodied Cognition and Alcohol Use Disorder: Frequency of Impairments and Relationship to Neurocognitive Assessments
Bell M, Weinstein A, Ciosek D, Reilly S, Wang Y, Yoon G. Embodied Cognition and Alcohol Use Disorder: Frequency of Impairments and Relationship to Neurocognitive Assessments. Brain Sciences 2025, 15: 228. PMID: 40149750, PMCID: PMC11940586, DOI: 10.3390/brainsci15030228.Peer-Reviewed Original ResearchAlcohol use disorderEmbodied cognitionTotal scoreExecutive functionUse disorderNeurocognitive assessmentCognitive declineMeasure executive functionFrequency of impairmentPotential protective factorsPremorbid IQEF impairmentsMemory domainDelayed recallOverall impairmentEF domainsCognitive processesNeurocognitive testsConcurrent validityFrequent impairmentCognitionSelf-regulationCognitive scienceImpairmentProtective factorsExploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan
Liberman A, Rozental Y, Ivasiy R, Kussainova A, Primbetova S, Madden L, Terlikbayeva A, Altice F. Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan. Journal Of Substance Use And Addiction Treatment 2025, 172: 209640. PMID: 39986387, PMCID: PMC12009200, DOI: 10.1016/j.josat.2025.209640.Peer-Reviewed Original ResearchNominal group techniqueHIV preventionCommunity health workersMulti-level barriersIn-depth interviewsHealth workersPWID clientsSocioecological modelCommunity stakeholdersOpioid use disorderFocus groupsHIV epidemicClinical directorsClinical sitesEducating clientsOpioid agonist therapyImprove implementationGroup techniqueResearch teamCHWsPolicy levelUse disorderCliniciansAlternative medicationsEligibilityAdaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial
Iscoe M, Hooper C, Levy D, Buchanan L, Dziura J, Meeker D, Taylor R, D’Onofrio G, Oladele C, Sarpong D, Paek H, Wilson F, Heagerty P, Delgado M, Hoppe J, Melnick E. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open 2025, 15: e098072. PMID: 39979056, PMCID: PMC11842997, DOI: 10.1136/bmjopen-2024-098072.Peer-Reviewed Original ResearchConceptsClinical decision supportMultiphase optimization strategyOpioid use disorderEmergency departmentInitiation of buprenorphineClinical decision support usePlan-Do-Study-Act cyclesLearning health system approachPlan-Do-Study-ActClinical decision support toolHealth system approachAdaptive decision supportUse disorderDecision supportAddiction treatmentPeer-reviewed journalsBuprenorphine initiationOpioid use disorder treatment initiationOpioid-related mortalityIntervention componentsED settingClinician feedbackInstitute Institutional Review BoardTreatment of opioid use disorderParticipating sitesThe Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder
Bassir Nia A, Farahmand Y, Griffith G, Ardavan M, Angarita G, Anand A, Pittenger C. The Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder. Current Addiction Reports 2025, 12: 20. DOI: 10.1007/s40429-025-00638-7.Peer-Reviewed Original ResearchEffects of psychedelicsOpioid use disorderConcurrent psychotherapyUse disorderTherapeutic effects of psychedelicsContribution of psychotherapyImpact of psychedelicsSubstance use disordersOpioid withdrawal symptomsTreatment of opioid use disorderFDA-approved medicationsOpioid use disorder treatmentPsychotherapy modalitiesPsychedelic treatmentPsychotherapy componentWithdrawal symptomsPsychotherapyPsychedelic trialsTherapy modelPsychedelicsAcute effectsDisordersAssociated with higher ratesTreatment discontinuationPotential therapeutic effectsNeural, Motivational, and Psychological Measures of Pain Avoidance Predict Future Alcohol Use in Adult Drinkers
Le T, Hughes F, Oba T, Li C. Neural, Motivational, and Psychological Measures of Pain Avoidance Predict Future Alcohol Use in Adult Drinkers. Addiction Biology 2025, 30: e70020. PMID: 39952897, PMCID: PMC11828665, DOI: 10.1111/adb.70020.Peer-Reviewed Original ResearchConceptsDorsal anterior cingulate cortexDrinking motivesAlcohol usePsychological measuresPercentage of heavy drinking daysRisk of alcohol use disorderAlcohol use severityAnterior cingulate cortexHeavy drinking daysAlcohol use disorderPain-related psychological measuresParticipants' alcohol usePromote alcohol usePainful electric shocksLevels of drinkingPain sensitivityAlcohol cravingDrinking severityGo/NoGo taskCingulate cortexNeural correlatesDrinking daysUse disorderAdult drinkersOvert actionsOnce-Weekly Semaglutide in Adults With Alcohol Use Disorder
Hendershot C, Bremmer M, Paladino M, Kostantinis G, Gilmore T, Sullivan N, Tow A, Dermody S, Prince M, Jordan R, McKee S, Fletcher P, Claus E, Klein K. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder. JAMA Psychiatry 2025, 82 PMID: 39937469, PMCID: PMC11822619, DOI: 10.1001/jamapsychiatry.2024.4789.Peer-Reviewed Original ResearchAlcohol use disorderUse disorderPeak breath alcohol concentrationMedium to large effect sizesNon-treatment-seeking participantsWeeks of outpatient treatmentAlcohol self-administrationSelf-administration taskReduce alcohol intakeOnce-weekly subcutaneous semaglutideLarge effect sizesAlcohol consumptionSubsample of individualsBreath alcohol concentrationEffects of once-weekly subcutaneous semaglutideTreatment-by-time interactionOnce-weekly semaglutideAlcohol cravingReduce cravingSelf-administrationDrinking outcomesSemaglutide treatmentDrinking daysReduce drinkingAmount of alcoholState Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder
Peltier M, Pegram D, Chander G, Weisner C, McKee S, Jones H, Chang G. State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder. Journal Of Women's Health 2025 PMID: 39932704, DOI: 10.1089/jwh.2024.0638.Peer-Reviewed Original ResearchOpioid use disorderChild abuse lawsChild abuse preventionRemoval of childrenAbuse lawsLegal actionCurrent legislationSubstance-exposed infantsComprehensive AddictionPunitive actionsIndividual statesRisk of overdoseAbuse preventionLegislationLife-saving medicationsLawState policyChild welfare workersSubstance useMandated trainingUse disorderMOUDIndividuals of colorPolicy variationReporting SystemPredicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model
Krishnan A, Ranjit Y, Zhou X, Altice F. Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model. Journal Of Behavioral Medicine 2025, 1-11. PMID: 39924604, DOI: 10.1007/s10865-025-00557-y.Peer-Reviewed Original ResearchCocaine use disorderSubstance use disordersBehavioral skillsInformation-motivation-behavioral (IMB) skills modelSkills modelInformation-motivation-behavioral skills modelAntiretroviral medication adherenceUse disorderAntiretroviral therapyART adherenceMedication adherenceDaily adherenceImprove ART adherenceMotivational barriersDisordersAntiretroviral therapy adherenceMotivational factorsPractical barriersReduce HIV transmissionEnhance ART adherenceSuboptimal adherenceVirological failureHIV transmissionCocaineAdherencePrescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial
Mobley A, Wegman M, Bazazi A, Shenoi S, Bromberg D, Ahmad A, Kamarulzaman A, Altice F. Prescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial. International Journal Of Drug Policy 2025, 137: 104733. PMID: 39923270, PMCID: PMC11875876, DOI: 10.1016/j.drugpo.2025.104733.Peer-Reviewed Original ResearchConceptsLinkage to HIV careHIV careIncrease linkage to HIV careTreatment-as-prevention strategiesHIV treatment cascadeHIV treatment outcomesOpen-label trialCox proportional hazards modelsPatient preference trialOpioid use disorderMalaysia’s largest prison.Impact of methadoneProportional hazards modelTreatment cascadeInverse probability weighted Cox proportional hazards modelAnalytic sampleStudy participantsCareTreatment outcomesPrescribed methadoneOpioidConfounding variablesHIVUse disorderHazards modelRepetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding
Michel A, Kang D, Fillingim R, Balderston N, Bond D, Steele V. Repetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding. Current Addiction Reports 2025, 12: 14. DOI: 10.1007/s40429-025-00620-3.Peer-Reviewed Original ResearchSubstance use disordersChronic painRepetitive transcranial magnetic stimulationTranscranial magnetic stimulationDiverse chronic pain conditionsChronic pain conditionsCo-occurring diseasesRTMS interventionMagnetic stimulationMagnetic resonance imagingEffective interventionsPain fieldPain conditionsSubstance use disorders fieldRepetitive transcranial magnetic stimulation applicationPainEffective treatmentUse disorderNarrative reviewClinical populationsSubstance useResonance imagingInterventionEvaluate relative efficacyClinical samplesMedications for opioid use disorder in traditional medicare beneficiaries: associations with age
Ganz D, Lai J, Cantor J, Agniel D, Simon K, Stein B, Taylor E. Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. Health Affairs Scholar 2025, 3: qxaf036. PMID: 40040649, PMCID: PMC11878533, DOI: 10.1093/haschl/qxaf036.Peer-Reviewed Original ResearchOpioid use disorderMOUD initiationIndex eventUse disorderTreat opioid use disorderAssociated with female sexRates of opioid use disorderIncreasing comorbidity scoreMultivariate logistic regressionAssociated with ageComorbidity scoreMedicare beneficiariesFemale sexOlder adultsAge-specific strategiesIncreased uptakeLogistic regressionOlder ageTraditional Medicare beneficiariesMOUDClaims dataMedicationSex-based Influences on White Matter Tract Integrity in Alcohol Use Disorder: a Systematic Review
Barrios N, Nartey N, Yue J, Riordan W, Kohler R, Verplaetse T, Roberts W, Carretta R, Banini B, Zhou H, Garcia-Rivas V, Blackford J, Zakiniaeiz Y. Sex-based Influences on White Matter Tract Integrity in Alcohol Use Disorder: a Systematic Review. Current Addiction Reports 2025, 12: 10. PMID: 40343159, PMCID: PMC12058214, DOI: 10.1007/s40429-025-00624-z.Peer-Reviewed Original ResearchWhite matter tract integrityAlcohol use disorderTract integritySex differencesUse disorderNeurotoxic effects of alcoholAlcohol-related health consequencesExamined sex differencesEffects of alcoholAlcohol use historyWell-characterized sampleDiffusion magnetic resonance imagingEvidence of sex-related differencesNeurobiological mechanismsPsychiatric comorbiditiesSubstance useSystematic reviewSex-related differencesNeurotoxic effectsIndividualized treatment optionsMagnetic resonance imagingDisordersAlcoholGoogle Scholar databasesTreatment options
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply